期刊文献+

红细胞作载体的超氧化物歧化酶用于脑缺血-再灌注研究 被引量:4

Superoxide Dismutase Encapsulated ErythrocytesUsed in the Study of Cerebral Ischemia-reperfusion
暂未订购
导出
摘要 研究用红细胞(RBC)作为超氧化物歧化酶(SOD)载体的可行性,将包载SOD的RBC(RBC-SOD)用于家兔脑缺血-再灌注(I-R)模型研究。采用51Cr标记测量RBC的循环半寿期( ),兔自身RBC的,RBC-SOD的RBC-SOD对脑I-R期间脂质过氧化物(LPO)的升高有一定程度的抑制作用。对照组再灌10min时,血浆一氧化氮(NO)浓度达最高;对照组和游离SOD组从缺血10min到再灌270min,NO浓度逐渐回落;但RBC-SOD组在270min的再灌期间,NO始终处于持续较高浓度状态。提示完整的RBC-SOD载体能够清除脑I-R时产生的超氧阴离子自由基( )。 The possibility of using red blood cells(RBC)as the carrier of superoxide dismutase(SOD)was studied in this paper.SOD was encapsulated into rabbit erythrocytes(RBC-SOD),and was iised in the study of cerebral ischemiareperfusion(I-R).The effect of RBC-SOD on cerebial I-R was observed.The circulation half-life()of RBC-SOD was deter-mined in rabbits by 51Cr radiolabel.was 13.4±1.5 days(n=6)for RBC,and was13.7±1.0 days(n=5) for RBC-SOD,The increase of lipid peroxidation(LPO)during cere-bral I-R was inhibited by RBC-SOD,The maximum concentration of nitric oxide (NO)inplasma occurred in 10 minutes following reperfusion;The concentration of nitric oxide re-duced gradually as reperfusion continued in both control and SOD groups,but it remained atarelatively high level continous during the 4.5 hours of reperfusion in RBC-SOD group. These results indicate that intact RBC-SOD could scavenge superoxide anion()producedduring cerebral I-R.
机构地区 中国医学科学院
出处 《中国医学科学院学报》 CAS CSCD 北大核心 1996年第5期392-396,共5页 Acta Academiae Medicinae Sinicae
基金 中国医学科学院重点项目
关键词 超氧化物歧化酶 红细胞 载体 脑缺血 再灌注 superoxide dismutase erythrocytes carrier cerebral ischemia-reperfusion
  • 相关文献

参考文献3

  • 1方允中,自由基与酶.基础理论及其在生物学和医学中的应用,1989年
  • 2张之南,中华血液学杂志,1987年,8卷,12期,729页
  • 3袁勤生,医药工业,1983年,4卷,4页

同被引文献43

  • 1王林杰,张永富(综述),王彭延(审).用红细胞作为药物或酶载体的研究[J].国外医学(生物医学工程分册),1995,18(2):81-86. 被引量:2
  • 2钱开诚,冷翠霞,张晰,高峰,柏乃庆,张钦辉.GMA红细胞悬液保存的实验研究[J].上海医学,1995,18(3):131-134. 被引量:11
  • 3Rechsteiner M.Uptake of proteins by red blood cells[ J ].Exptl Cell Res, 1975,93:487.
  • 4Green BR, Miller J, Crosby W.Enhancement of iron chelaation by desferrioxamine entrapped in red blood cell ghosts[J].Blood, 1981,57(5) :866.
  • 5Alvarez FJ, Herraez A, Tejedor MC.Fluorescence analysis of carrier rat and human erythrocytes loaded with FITC-dextran [ J].Cytometry, 1996,24(2): 181.
  • 6Kravtzoff R, Rupars C, Lagurre M, et al.Erythrocyte as carriers for L-asparaginase.Methodological and mouse in-vivo studies [ J ].J Pharm Pharmacol , 1990,42:473.
  • 7Sanz S, Lizano C, Luque J, et al.In vitro and in vivo study of glutamate dehydrogenase encapsulated into mouse erythrocyte by a hypotonic dialysis procedure[J].Life Sci, 1999,65(26) :2781.
  • 8Garin MI, Lopez RM, Luque J.Pharmacokinetic properties and invivo biological activity of recombinant human erythropoietin encapsulated in red blood cells[J].Cytokine, 1997,9(1):66.
  • 9Lotero LA, Olmos G, Diez JC.Delivery to macrophages and toxic action of etoposide carried in mouse red blood cells [ J ].Biochim Biophy Acta, 2003,1620:160.
  • 10Pemo CF, Santoro N, Balestra E, et al.Red blood cells mediated delivery of 9-(2-phosphonylmethoxyethyl) adenine to primary macrophages: efficiency, metabolism and activity against humane immunodeficiency virus or herpes simplex virus [ J ].AntiviralRes, 1

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部